Healthcare

• Acrux Limited concentrates its strategy on specialty generic formulation and us distribution royalties.

• Actinogen Medical Limited concentrates its strategy on 11β-hsd1 brain-penetrant inhibitors and cognitive preservation.

• Clover Corporation Limited concentrates its strategy on high-dha bioactive lipids and infant nutrition recovery.

• Avecho Biotechnology Limited concentrates its strategy on lipid-based drug delivery platforms and phase 3 insomnia trials.

• Biome Australia Ltd concentrates its strategy on pharmacy medicalMarketingand clinical trial validation.

• Biotron Limited concentrates its strategy on viroporin small molecule inhibition and hiv clinical science.

• Botanix Pharmaceuticals Limited concentrates its strategy on dermatology prescription dynamics and formulary expansion.